Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same
The present invention is directed to an oral dosage form for administration to a warm blooded animal of the combination of tegafur, uracil, and folinic acid to potentiate coadministered oxaliplatin for the treatment of tumors. This invention provides a dosage form and a method of administering an an...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Chazard, Michel |
description | The present invention is directed to an oral dosage form for administration to a warm blooded animal of the combination of tegafur, uracil, and folinic acid to potentiate coadministered oxaliplatin for the treatment of tumors.
This invention provides a dosage form and a method of administering an anti-tumor composition comprising tegafur, uracil and folinic acid to potentiate the coadministration of oxaliplatin. |
format | Patent |
fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_06602870</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>06602870</sourcerecordid><originalsourceid>FETCH-uspatents_grants_066028703</originalsourceid><addsrcrecordid>eNqNjLEKAjEQRK-xEPUf9gMiHAqnvSh2NvayXja5QJI9sgn4A_63uUOwtZlhhnmzbN63hB40C1oCwylMAqiDi05ywuw4AhvIA0HP4eniryKLpiQFJWHvvKqkr1QPNWkFGDXwC70bfUXinAPlgfUEF3HRzq-CgdbNwqAX2nx91cDlfD9dt0VGzBSzPGzCydqua3fHQ7v_Y_IB6rFLCQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same</title><source>USPTO Issued Patents</source><creator>Chazard, Michel</creator><creatorcontrib>Chazard, Michel ; Bristol-Myers Squibb Company</creatorcontrib><description>The present invention is directed to an oral dosage form for administration to a warm blooded animal of the combination of tegafur, uracil, and folinic acid to potentiate coadministered oxaliplatin for the treatment of tumors.
This invention provides a dosage form and a method of administering an anti-tumor composition comprising tegafur, uracil and folinic acid to potentiate the coadministration of oxaliplatin.</description><language>eng</language><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6602870$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6602870$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Chazard, Michel</creatorcontrib><creatorcontrib>Bristol-Myers Squibb Company</creatorcontrib><title>Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same</title><description>The present invention is directed to an oral dosage form for administration to a warm blooded animal of the combination of tegafur, uracil, and folinic acid to potentiate coadministered oxaliplatin for the treatment of tumors.
This invention provides a dosage form and a method of administering an anti-tumor composition comprising tegafur, uracil and folinic acid to potentiate the coadministration of oxaliplatin.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNjLEKAjEQRK-xEPUf9gMiHAqnvSh2NvayXja5QJI9sgn4A_63uUOwtZlhhnmzbN63hB40C1oCwylMAqiDi05ywuw4AhvIA0HP4eniryKLpiQFJWHvvKqkr1QPNWkFGDXwC70bfUXinAPlgfUEF3HRzq-CgdbNwqAX2nx91cDlfD9dt0VGzBSzPGzCydqua3fHQ7v_Y_IB6rFLCQ</recordid><startdate>20030805</startdate><enddate>20030805</enddate><creator>Chazard, Michel</creator><scope>EFH</scope></search><sort><creationdate>20030805</creationdate><title>Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same</title><author>Chazard, Michel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_066028703</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Chazard, Michel</creatorcontrib><creatorcontrib>Bristol-Myers Squibb Company</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Chazard, Michel</au><aucorp>Bristol-Myers Squibb Company</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same</title><date>2003-08-05</date><risdate>2003</risdate><abstract>The present invention is directed to an oral dosage form for administration to a warm blooded animal of the combination of tegafur, uracil, and folinic acid to potentiate coadministered oxaliplatin for the treatment of tumors.
This invention provides a dosage form and a method of administering an anti-tumor composition comprising tegafur, uracil and folinic acid to potentiate the coadministration of oxaliplatin.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_uspatents_grants_06602870 |
source | USPTO Issued Patents |
title | Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T17%3A17%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Chazard,%20Michel&rft.aucorp=Bristol-Myers%20Squibb%20Company&rft.date=2003-08-05&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E06602870%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |